Characterising this bidirectional relationship is an open research question, and the work is early-stage
The peptide can't mobilize fat when insulin is telling your body to store energy
In some cases, low-quality or improperly administered injections may not provide the intended benefits and could even exacerbate symptoms
Through its effects on insulin sensitivity and insulin resistance, Tirzepatide helps stabilize blood sugar while supporting substantial weight loss
Mechanism difference Semaglutide (GLP-1 agonist): appetite regulation, satiety, improved glycemic control (New England Journal of Medicine) Tirzepatide (GLP-1/GIP agonist): broader incretin effects, robust appetite/weight effects (New England Journal of Medicine) AOD-9604: targeted fat-metabolism signaling
Intermediate users may increase the dose to 400500 micrograms daily